More on Walgreen's FQ4

Walgreen (WAG) reports total sales at comparable sales rose 4.6% as a higher average basket size helped to make up for lower traffic in stores.

Prescription sales at comparable stores rose 6.4% during the period on a prescription count of 203M.

The company says a joint synergy program with Alliance Boots led to first-year synergies of $154M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs